CNS Drugs

, Volume 18, Issue 1, pp 37–48 | Cite as

Cognitive Effects of Long-Term Benzodiazepine Use

A Meta-Analysis
  • Melinda J. Barker
  • Kenneth M. Greenwood
  • Martin Jackson
  • Simon F. CroweEmail author
Original Research Article


Introduction: While benzodiazepines are the most widely used psychotropic drugs, there are relatively few studies that have examined deficits in cognitive functioning after long-term use. The literature that is available is difficult to interpret due to conflicting results as well as a variety of methodological flaws.

Objective: To systematically evaluate and integrate the available research findings to determine the effect of long-term benzodiazepine use on cognitive functioning using meta-analytical techniques.

Methods: Thirteen research studies that employed neuropsychological tests to evaluate cognitive performance after long-term use of benzodiazepine medication met inclusion criteria. The neuropsychological tests employed in these 13 studies were each categorised as measuring one of 12 cognitive domains. Separate effect sizes were calculated for each of the 12 cognitive categories. Each study was only allowed to contribute one effect size to each cognitive category by averaging together the effect sizes from the same study if more than one type of test was used to measure a particular category. This strategy resulted in equal weight being given to each study per category, regardless of the number of tests in that category.

Results: The overall mean number of patients who were benzodiazepine users was 33.5 (SD ± 28.9) and the mean number of controls was 27.9 (SD ± 19.6). The duration of benzodiazepine use ranged from 1 to 34 (mean 9.9) years. Long-term benzodiazepine users were consistently more impaired than controls across all cognitive categories examined, with effect sizes ranging in magnitude from −1.30 to −0.42. The mean weighted effect size was −0.74 (SD ± 0.25). None of the effect sizes had 95% CIs that spanned zero and, therefore, all of these effects were significant and different to zero.

Conclusion: Moderate-to-large weighted effect sizes were found for all cognitive domains suggesting that long-term benzodiazepine users were significantly impaired, compared with controls, in all of the areas that were assessed. However, this study has several limitations, one being that it includes a relatively small number of studies. Further studies need to be conducted; ideally, well designed, controlled studies that thoroughly investigate certain areas of cognitive functioning and present data in such a way so as to be amenable to inclusion in a meta-analysis. Incorporating the information from these studies into a larger meta-analysis would allow for a more thorough and statistically sound investigation of the effects of moderator variables. The observation that long-term benzodiazepine use leads to a generalised effect on cognition has numerous implications for the informed and responsible prescription of these drugs.


Verbal Memory Psychomotor Speed Visuospatial Ability High Effect Size Weighted Effect Size 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript. The results reported in this manuscript form part of M. Barker’s doctoral thesis.


  1. 1.
    Lader M, Petursson H. Long term effects of benzodiazepines. Neuropharmacology 1983; 22(4): 527–33PubMedCrossRefGoogle Scholar
  2. 2.
    Lucki I, Rickeis K. The behavioral effects of benzodiazepines following long-term use. Psychopharmacol Bull 1986; 22(2): 424–33PubMedGoogle Scholar
  3. 3.
    Balter MB, Manheimer DI, Mellinger GD, et al. A cross-national comparison of anti-anxiety/sedative drug use. Curr Med Res Opin 1984; 8 Suppl. 4: 5–20Google Scholar
  4. 4.
    Chen Y. Long-term benzodiazepine treatment: is it ever justified? Hum Psychopharmacol Clin Exp 1990; 5(4): 301–12CrossRefGoogle Scholar
  5. 5.
    Mellinger GD, Balter BB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984; 251(3): 375–9PubMedCrossRefGoogle Scholar
  6. 6.
    Zandstra SM, Furer JW, van de Lisdonk EH, et al. Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 139–44PubMedCrossRefGoogle Scholar
  7. 7.
    Pollack MH. Innovative uses of benzodiazepines in psychiatry. Can J Psychiatry 1993; 38(9 Suppl. 4): 122–6Google Scholar
  8. 8.
    McEvoy GK, Welsh OH, Litvak K. American Hospital Formulary Service (AHFS) drug information 2002. Bethesda (MD): American Society of Health System Pharmacists, 2002Google Scholar
  9. 9.
    Gudex C. Adverse effects of benzodiazepines. Soc Sci Med 1991; 33(5): 587–96PubMedCrossRefGoogle Scholar
  10. 10.
    Ashton H. Toxicity and adverse consequences of benzodiazepine use. Psychiatr Ann 1995; 25(3): 158–65Google Scholar
  11. 11.
    Ashton H. Adverse effects of prolonged benzodiazepine use. Adverse Drug React Bull 1986; 118: 440–3CrossRefGoogle Scholar
  12. 12.
    Lader MH. Psychological effects of buspirone. J Clin Psychiatry 1982; 43(12): 62–7PubMedGoogle Scholar
  13. 13.
    Birzele HJ. Benzodiazepine induced amnesia after long-term medication and during withdrawal. Eur Rev Appl Psychol 1992; 42(4): 277–82Google Scholar
  14. 14.
    Tata PR, Rollings J, Collins M, et al. Lack of cognitive recovery following withdrawal from long-term benzodiazepine use. Psychol Med 1994; 24(1): 203–13PubMedCrossRefGoogle Scholar
  15. 15.
    Golombok S, Moodley P, Lader M. Cognitive impairment in long-term benzodiazepine users. Psychol Med 1988; 18(2): 365–74PubMedCrossRefGoogle Scholar
  16. 16.
    Lucki I, Rickeis K, Geller AM. Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology 1986; 88(4): 426–33PubMedCrossRefGoogle Scholar
  17. 17.
    Sakol MS, Power KG. The effects of long-term benzodiazepine treatment and graded withdrawal on psychometric performance. Psychopharmacology 1988; 95(1): 135–8PubMedCrossRefGoogle Scholar
  18. 18.
    Golombok S. Causes, effects and treatment of long-term benzodiazepine use: a review of psychological perspectives. Hum Psychopharmacol Clin Exp 1989; 4(1): 15–20CrossRefGoogle Scholar
  19. 19.
    Petursson H, Gudjonsson GH, Lader MH. Psychometric performance during withdrawal from long-term benzodiazepine treatment. Psychopharmacology 1983; 81: 345–9PubMedCrossRefGoogle Scholar
  20. 20.
    Bergman H, Borg S, Engelbrektson K, et al. Dependence on sedative-hypnotics: neuropsychological impairment, field dependence and clinical course in a 5-year follow-up study. Br J Addict 1989; 84: 547–53PubMedCrossRefGoogle Scholar
  21. 21.
    Bergman H, Borg S, Holm S. Neuropsychological impairment and exclusive abuse of sedatives or hypnotics. Am J Psychiatry 1980; 137(2): 215–7PubMedGoogle Scholar
  22. 22.
    Gorenstein C, Bernik MA, Pompeia S, et al. Impairment of performance associated with long-term use of benzodiazepines. J Psychopharmacol 1995; 9(4): 313–8PubMedCrossRefGoogle Scholar
  23. 23.
    Brosan L, Broadbent D, Nutt D, et al. Performance effects of diazepam during and after prolonged administration. Psychol Med 1986; 16: 561–71PubMedCrossRefGoogle Scholar
  24. 24.
    Aranko K, Mattila MJ, Bordignon D. Psychomotor effects of alprazolam and diazepam during acute and subacute treatment, and during follow-up phase. Acta Pharmacol Toxicol (Copenh) 1985; 56: 364–72CrossRefGoogle Scholar
  25. 25.
    Allen D, Curran HV, Lader M. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects. Eur J Clin Pharmacol 1991; 40: 355–62PubMedCrossRefGoogle Scholar
  26. 26.
    Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol 2002; 22: 285–93PubMedCrossRefGoogle Scholar
  27. 27.
    Chaves ML, Bianchin M, Peccin S, et al. Chronic use of benzodiazepines and cognitive deficit complaints: a risk factor study. Ital J Neurol Sci 1993; 14(6): 429–35PubMedCrossRefGoogle Scholar
  28. 28.
    Gorenstein C, Bernik MA, Pompeia S. Differential acute psychomotor and cognitive effects of diazepam on long-term benzodiazepine users. Int Clin Psychopharmacol 1994; 9(3): 145–53PubMedCrossRefGoogle Scholar
  29. 29.
    Crowe SF. Neuropsychological effects of the psychiatric disorders. Melbourne (VIC): Hardwood Academic, 1998Google Scholar
  30. 30.
    Gladsjo JA, Rapaport MH, McKinney R, et al. A neuropsychological study of panic disorder: negative findings. J Affect Disord 1998; 49(2): 123–31PubMedCrossRefGoogle Scholar
  31. 31.
    Chavez EL, Trautt GM, Brandon A, et al. Effects of test anxiety and sex of subject on neuropsychological test performance: finger tapping, trail making, digit span and digit symbol tests. Percept Motor Skills 1983 Jun; 56(3): 923–9PubMedCrossRefGoogle Scholar
  32. 32.
    Curran HV. Memory functions, alertness and mood of long-term benzodiazepine users: a preliminary investigation of the effects of a normal daily dose. J Psychopharmacol 1992; 6(1): 69–75PubMedCrossRefGoogle Scholar
  33. 33.
    Toenne U, Hiltunen AJ, Vikander B, et al. Neuropsychological changes during steady-state drug use, withdrawal and abstinence in primary benzodiazepine-dependent patients. Acta Psychiatr Scand 1995; 91(5): 299–304CrossRefGoogle Scholar
  34. 34.
    Hendler N, Cimini C, Ma T, et al. A comparison of cognitive impairment due to benzodiazepines and to narcotics. Am J Psychiatry 1980; 137(7): 828–30PubMedGoogle Scholar
  35. 35.
    Rickels K, Lucki I, Schweizer E, et al. Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation. J Clin Psychopharmacol 1999; 19(2): 107–13PubMedCrossRefGoogle Scholar
  36. 36.
    Salzman C, Fisher J, Nobel K, et al. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992; 7(2): 89–93CrossRefGoogle Scholar
  37. 37.
    Vignola A, Lamoureux C, Bastion CH, et al. Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adults. J Gerontol B Psychol Sci Soc Sei 2000; 55B: 54–62Google Scholar
  38. 38.
    Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995Google Scholar
  39. 39.
    Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. 2nd ed. New York: Oxford University Press, 1998Google Scholar
  40. 40.
    Graf P, Squire LR, Mandler G. The information that amnesic patients do not forget. J Exp Psychol 1984; 10(1): 164–78Google Scholar
  41. 41.
    Graf P, Mandler G. Activation makes words more accessible, but not necessarily more retrievable. J Verbal Learn Verbal Behav 1984; 23: 553–68CrossRefGoogle Scholar
  42. 42.
    Ryan JJ, Lopez SJ, Paolo AM. Digit span performance of persons 75–96 years of age: base rates and associations with selected demographic variables. Psychol Assess 1996; 8(3): 324–7CrossRefGoogle Scholar
  43. 43.
    Brown J, Packham DW. The effect of prior recall on multiple response recognition. Q J Exp Psychol 1967; 19(4): 356–61PubMedCrossRefGoogle Scholar
  44. 44.
    Curran S, Hindmarch I, Wattis JP, et al. Critical flicker fusion in normal elderly subjects: a cross-sectional community study. Curr Psychol Res Rev 1990; 9(1): 25–34CrossRefGoogle Scholar
  45. 45.
    Wechsler D. Wechsler adult intelligence scale: revised manual. San Antonio (TX): Psychological Incorporation, 1981Google Scholar
  46. 46.
    Cooper AJ. Benzodiazepines: toward more logical use. Scott Med J 1982; 27: 297–304PubMedGoogle Scholar
  47. 47.
    Rosenthal R. Meta-analytic procedures of social research. Rev. ed. London: Sage Publications, 1991Google Scholar
  48. 48.
    Cohen J. Statistical power analyses for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates, 1988Google Scholar
  49. 49.
    Hedges LV, Olkin I. Statistical methods for meta-analysis. New York: Academic Press, 1985Google Scholar
  50. 50.
    Kilic C. Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia/panic patients. Psychol Med 1999; 29(1): 225–31PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Melinda J. Barker
    • 1
  • Kenneth M. Greenwood
    • 1
  • Martin Jackson
    • 1
  • Simon F. Crowe
    • 1
    Email author
  1. 1.School of Psychological ScienceLa Trobe UniversityBundooraAustralia

Personalised recommendations